PYPD (PolyPid) Interest Expense : $-0.95 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PolyPid Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PolyPid's interest expense for the three months ended in Dec. 2024 was $ -0.29 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.95 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PolyPid's Operating Income for the three months ended in Dec. 2024 was $ -8.22 Mil. PolyPid's Interest Expense for the three months ended in Dec. 2024 was $ -0.29 Mil. PolyPid did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PolyPid Interest Expense Historical Data

The historical data trend for PolyPid's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPid Interest Expense Chart

PolyPid Annual Data

Trend

Dec13

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.54

-0.93

-0.95

PolyPid Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-0.35	-0.14	-0.17	-0.35	-0.29

PolyPid Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.95 Mil.

PolyPid (NAS:PYPD) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PolyPid's Interest Expense for the three months ended in Dec. 2024 was $-0.29 Mil. Its Operating Income for the three months ended in Dec. 2024 was $-8.22 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was $1.91 Mil.

PolyPid's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

PolyPid did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

PolyPid Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PolyPid Ltd (NAS:PYPD) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Hasivim Street, P.O Box 7126, Petach Tikva, ISR, 495376

Website

https://www.polypid.com

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.